SANTA CLARA, Calif. & BILLERICA, Mass.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A) and Seahorse Bioscience today announced they have signed a definitive agreement under which Agilent will acquire Seahorse Bioscience, a leader in providing instruments and assay kits for measuring cell metabolism and bioenergetics. Exploration into cell metabolism is rapidly accelerating as the links between mitochondrial function and disease are increasingly revealed. Seahorse Bioscience’s leading techn
For more information, please visit
http://www.businesswire.com/news/home/20[...]rse-Bioscience-Industry-Leader